WebmedCentral.com :: Article Review View

Submited on: 19 Dec 2011 01:24:31 PM GMT

Published on: 19 Dec 2011 03:31:23 PM GMT

Review response

Posted by Dr. Oliver Grundmann on 05 Mar 2012 05:31:05 PM GMT

1	Is the subject of the article within the scope of the subject category?	Yes
2	Are the interpretations / conclusions sound and justified by the data?	No
3	Is this a new and original contribution?	No
4	Does this paper exemplify an awareness of other research on the topic?	No
5	Are structure and length satisfactory?	No
6	Can you suggest brief additions or amendments or an introductory statement that will increase the value of this paper for an international audience?	Yes
7	Can you suggest any reductions in the paper, or deletions of parts?	Yes
8	Is the quality of the diction satisfactory?	No
9	Are the illustrations and tables necessary and acceptable?	No
10	Are the references adequate and are they all necessary?	Yes
11	Are the keywords and abstract or summary informative?	No

Other Comments:
The review paper submitted by Rahim et al. discusses the visualization of aminoglycosides for - what appears to be - better understanding in the clinical and instructional setting. Although this approach may provide educational benefits, the authors do not provide any data that would indicate that students benefit from this approach. Has this actually been tested in the educational setting versus an older method? It would be interesting to see where these color schemes have been used and if there is an actual, measurable advantage of using them.
Competing interests:
No competing interests to declare
Invited by the author to review this article? :
No
Have you previously published on this or a similar topic?:
No
References:
None
Experience and credentials in the specific area of science:

Teaching pharmacology and medicinal chemistry to PharmD students
How to cite: Grundmann O .Review response[Review of the article 'An Illustrated Review About Aminoglycosides ' by Kanasin R].WebmedCentral 2012;3(3):WMCRW001557

Rating
Rating	1	2	3	4	5	6	7	8	9

Report abuse